Search results

Gawlik KI1, Harandi VM2, Cheong RY3, Petersén Å3, Durbeej M2.1Muscle Biology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden.2Muscle Biology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden.3Translational Neuroendocrine Research Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden.Matrix Biology 70: 36-79 (20

https://www.huntington-research.lu.se/laminin-a1-reduces-muscular-dystrophy-dy2j-mice - 2025-12-15

Vercruysse P, Vieau D, Blum D, Petersén Å and Dupuis L.Frontiers in Molecular Neuroscience 11:2 (2018)AbstractNeurodegenerative diseases (NDDs) are disorders characterized by progressive deterioration of brain structure and function. Selective neuronal populations are affected leading to symptoms which are prominently motor in amyotrophic lateral sclerosis (ALS) or Huntington's disease (HD), or co

https://www.huntington-research.lu.se/hypothalamic-alterations-neurodegenerative-diseases-and-their-relation-abnormal-energy-metabolism - 2025-12-15

Please note, that all links on this page open a new webpage. Knut and Alice Wallenberg FoundationThrough the research program Wallenberg Clinical Scholars, the Knut and Alice Wallenberg Foundation are funding 24 of the foremost clinical researchers in Sweden. Almost SEK 800 million are used for funding over ten years. Åsa Petersén was appointed Wallenberg Clinical Scholar 2020 and will receive SEK

https://www.huntington-research.lu.se/funding - 2025-12-15

Our researchÅsa Mackenzie’s research group has as goal to solve the internal organization of the subthalamic area with the purpose to decode neurobiological underpinnings of emotion. Despite their impact on well-being, affective symptoms of Parkinson’s disease, including anxiety, apathy and depression, have remained under-investigated. The underlying anatomy and neurocircuitry remain to be fully e

https://www.multipark.lu.se/molecular-neuroanatomy - 2025-12-15

Multidisciplinary research on neurodegenerative diseases Multidisciplinary research on neurodegenerative diseases and related brain disorders with the aim to better understand, treat, and cure. A strategic research area with pioneering rootsMultiPark is a strategic research area supported by the Swedish Government since 2010.We aim to unravel basic disease mechanisms, improve diagnostic and progno

https://www.multipark.lu.se/about-multipark - 2025-12-15

Donna Wilcock, Indiana University School of Medicine, USAThomas Perlmann, Karolinska Institutet, StockholmMarina Romero-Ramos, Aarhus University, DenmarkBart De Strooper, KU Leuven, Belgium, and University College London, EnglandGünther Deuschl, Christian-Albrechts-University Kiel, GermanyDavid Devos, Medical Pharmacology CHU, University of Lille, INSERM U1172Li-Huei Tsai, Massachusetts Institute

https://www.multipark.lu.se/frontiers-neuroscience-seminar-series/previous-frontiers-neuroscience-talks - 2025-12-15

How MultiPark research creates value for society Our research is of high societal relevance. Living with a progressive neurodegenerative disease has detrimental effects for the individual and next of kins, including inducing major societal challenges. Moreover, major neurocognitive disorders (“dementia”) are considered a global health challenge and priority.  Our goal is to early detect those at r

https://www.multipark.lu.se/societal-impact - 2025-12-15

Evidence-based clinical guidelinesOur senior researchers contribute to the development of national and international evidence-based (GRADE) clinical guidelines since 2014, advancing standards of care across the field. Below are some examples:Parkinson-Krankheit: Leitlinien fur Diagnostik und Therapie in der Neurologie.German evidence-based guidelines for Parkinson´s disease (Evidence-grade: S2k).

https://www.multipark.lu.se/clinical-guidelines - 2025-12-15

PROGRAM FOR 202524 April, 16:00, Segerfalk lecture hall, BMC A10Professor Bill Seeley, UCSF Memory and Aging Center, USALecture title: "Upstream pathogenesis in FTD/ALS"Lecture host: Alexander Santillo Bio-sketch:Professor Seeley is a behavioral neurologist who specializes in neurodegenerative dementia. His lab has taken a leading role in identifying the neuron types, brain regions, and large-scal

https://www.multipark.lu.se/frontiers-neuroscience-seminar-series - 2025-12-15

MultiPark researchers contribute to international recommendations regarding diagnostics, prognostics, and treatments of neurodegenerative disorders. Below are some examples. 2025The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study.Ashton NJ, Keshavan A, Brum WS, Andreasson U, Arslan B, Droescher M, Barghorn S, Vanbrabant J, Lambrechts

https://www.multipark.lu.se/international-recommendations - 2025-12-15

Travel GrantsMultiPark has a call to apply for travel grants. Eligible to apply for the grants are those from PhD student level and up to, but not including, the position of group leader and/or docent. Applications must be submitted at least 5 weeks prior to the event taking place.Deadlines to submit applications during 2025:• 15 February• 15 April• 15 June• 15 August• 15 October• 15 December Trav

https://www.multipark.lu.se/funding-opportunities - 2025-12-15

Are you involved in innovative research that may lead to the development of novel diagnostics or therapeutics or that may pave the way for new research tools, technologies or methodologies? You now have the possibility to get support, up to 200 000 SEK (including indirect costs) from MultiPark.MultiPark is offering you an opportunity to validate your discovery or to trigger an industrial interacti

https://www.multipark.lu.se/innovation/innovation-support - 2025-12-15

15 May 2026 15:00 to 16:00 | Lecture/talk Welcome to a Frontiers in Neuroscience talk by Juho Joutsa, MD, PhD Professor of neurology, University of Turku, Finland. Lecture title: Post-stroke movement disordersLecture host: Per Odin About the speaker:Prof. Joutsa is a movement disorder neurologist with special interest in lesion-induced symptoms andneuromodulation (rTMS, DBS, MRgFUS). He completed 

https://www.multipark.lu.se/calendar/frontiers-neuroscience-seminar-post-stroke-movement-disorders - 2025-12-15

6 February 2026 09:00 | Thesis defence Thesis: Blood Based Biomarkers in Alzheimer’s disease: Bridging the diagnostic and prognostic gapPhD student: Divya BaliMain supervisor: professor Oskar HanssonOpponent: professor Pascual Sánchez-Juan, MadridChair: professor Tomas Deierborg About the eventLocation:To be announcedContact:divya [dot] bali [at] med [dot] lu [dot] se Save the event to your calend

https://www.multipark.lu.se/calendar/thesis-defense-blood-based-biomarkers-alzheimers-disease-bridging-diagnostic-and-prognostic-gap - 2025-12-15

5 February 2026 16:00 | Seminar Welcome to a Frontiers in Neuroscience talk by DR. PASCUAL SÁNCHEZ-JUAN, Center for Research on Neurological Diseases (CIEN)Lecture title: CIEN – A unique center for Neurodegenerative DiseasesLecture host: Professor Oskar Hansson  About the speaker:Dr. Pascual Sánchez-Juan is a neurologist and researcher who specializes in genetic epidemiology and biomarkers for neu

https://www.multipark.lu.se/calendar/frontiers-neuroscience-seminar-cien-unique-center-neurodegenerative-diseases - 2025-12-15

26 February 2026 09:00 to 12:00 | Thesis defence Thesis: Risk Factors for Cognitive Decline and Neurodegenerative Diseases – The impact of diet, demographics and cardiometabolic healthPhD student: Isabelle GlansMain supervisor: docent Sebastian PalmqvistOpponent: professor Geir Selbæk, OsloChair: professor Elisabet Londos About the eventLocation:To be announcedContact:isabelle [dot] glans [at] med

https://www.multipark.lu.se/calendar/thesis-defense-risk-factors-cognitive-decline-and-neurodegenerative-diseases-impact-diet - 2025-12-15

7 May 2026 09:00 | Conference The next Neuroscience Day will be held on Thursday, May 7, 2026. Save the date!The 2026 program will feature invited lectures, a "Meet the Speakers" session, and poster presentations by young investigators.Link to Neuroscience Day website. About the eventLocation:To be announcedContact:megg [dot] garcia-ryde [at] med [dot] lu [dot] se Save the event to your calendar

https://www.multipark.lu.se/calendar/neuroscience-day-2026 - 2025-12-15

  Part of the MultiPark mission involves stimulating research towards generating innovative solutions - products, services, methods or treatments - that can contribute financially to society. We continuously support exciting projects with commercial merits that have a chance of benefitting patients in the shorter time span. Through broad calls for new innovations, across the scientific spectrum, t

https://www.multipark.lu.se/innovation - 2025-12-15

MultiPark MultiPark (Multidisciplinary Parkinson and Alzheimer Research) is a strategic research area (SRA) supported by the Swedish Government. Through a comprehensive scientific programme we aim at unraveling basic disease mechanisms, improving diagnostics precision, and developing efficient methods of treatment and carefor people affected by neurodegenerative diseases. Building on a tradition o

https://www.multipark.lu.se/frontpage-v0 - 2025-12-15

Upcoming events     Previous events 3 December 2020 MultiPark PI-meeting (virtual meeting) 4 December 2020 MultiPark Retreat 2020 (virtual meeting) 16 Sep, 30 Sep, 7 Oct, 21 Oct 2020 MultiPark Innovation Days 2020 30 October 2019 Study visit by Parkinson Skåne 13 September 2019                      MultiPark senior researcher meeting                                                  12 September 20

https://www.multipark.lu.se/multipark-events - 2025-12-15